Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Gastritis | Research

Atrophic gastritis rather than Helicobacter pylori infection can be an independent risk factor of colorectal polyps: a retrospective study in China

Authors: Zhang Shao-hua, Ren Lin-lin, Su Shen, Tang Yun-he, Tian Zi-bin, Liu Yi, Mao Tao

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

Colonoscopy is considered the most effective screening method for colorectal polyps. However, the longevity and complexity of the procedure makes it less desirable to screen for colorectal polyps in the general population. Therefore, it is essential to identify other independent risk factors. In this study, we explored the link between Hp infection, atrophic gastritis, and colorectal polyps to identify a new potential risk factors of colorectal polyps.

Methods

In this study, atrophic gastritis and intestinal polyps were diagnosed by endoscopy and pathology. All the 792 patients in this retrospective study were divided into sub-groups based on the presence of colorectal polyps. The correlation between polyps and atrophic gastritis was analyzed using the chi-square test and Kruskal-Wallis test. The receiver operating characteristic (ROC) curve was used to compare the predictive value for colorectal polyps between Hp infection and atrophic gastritis. Binary logistic regression was utilized to identify independent risk factors for colorectal polyps.

Results

Patients with colorectal polyps were primarily male with advanced age, and the number of patients with colorectal polyps had a higher association with smoking, alcohol drinking, and Hp infection than the control group. A positive correlation between the number of colorectal polyps and the severity of atrophic gastritis was observed. ROC analysis showed that atrophic gastritis was a better risk factors for colorectal polyps. Multivariate analysis identified atrophic gastritis as an independent risk factor for colorectal polyps (OR 2.294; 95% CI 1.597–3.296).

Conclusions

Atrophic gastritis confirmed could be an independent risk factors for colorectal polyps.
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424.CrossRef Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424.CrossRef
2.
go back to reference Haumaier F, Sterlacci W, Vieth M. Histological and molecular classification of gastrointestinal polyps. Best Pract Res Clin Gastroenterol. 2017;31(4):369–79.CrossRefPubMed Haumaier F, Sterlacci W, Vieth M. Histological and molecular classification of gastrointestinal polyps. Best Pract Res Clin Gastroenterol. 2017;31(4):369–79.CrossRefPubMed
3.
go back to reference Wolf A, Fontham E, Church T, Flowers C, Guerra C, LaMonte S, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. Cancer J Clin. 2018;68(4):250–81.CrossRef Wolf A, Fontham E, Church T, Flowers C, Guerra C, LaMonte S, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. Cancer J Clin. 2018;68(4):250–81.CrossRef
5.
go back to reference Sugano K, Tack J, Kuipers E, Graham D, El-Omar E, Miura S, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353–67.CrossRefPubMed Sugano K, Tack J, Kuipers E, Graham D, El-Omar E, Miura S, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353–67.CrossRefPubMed
6.
go back to reference Hatakeyama M. Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis. Cell Host Microbe. 2014;15(3):306–16.CrossRefPubMed Hatakeyama M. Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis. Cell Host Microbe. 2014;15(3):306–16.CrossRefPubMed
8.
go back to reference Xie Y, Zhou J, Zhao Y, Zhang T, Mei L. H. pylori modifies methylation of global genomic DNA and the gastrin gene promoter in gastric mucosal cells and gastric cancer cells. Microb Pathog. 2017;108:129–36.CrossRefPubMed Xie Y, Zhou J, Zhao Y, Zhang T, Mei L. H. pylori modifies methylation of global genomic DNA and the gastrin gene promoter in gastric mucosal cells and gastric cancer cells. Microb Pathog. 2017;108:129–36.CrossRefPubMed
9.
go back to reference Waldum H, Fossmark R, Gastritis. Gastric Polyps and Gastric Cancer. Int J Mol Sci. 2021;22(12). Waldum H, Fossmark R, Gastritis. Gastric Polyps and Gastric Cancer. Int J Mol Sci. 2021;22(12).
10.
go back to reference Siddheshwar R, Muhammad K, Gray J, Kelly S. Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol. 2001;96(1):84–8.CrossRefPubMed Siddheshwar R, Muhammad K, Gray J, Kelly S. Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol. 2001;96(1):84–8.CrossRefPubMed
11.
go back to reference Lu D, Wang M, Ke X, Wang Q, Wang J, Li D, et al. H. pyloriAssociation between infection and colorectal polyps: a Meta-analysis of Observational Studies. Front Med. 2021;8:706036.CrossRef Lu D, Wang M, Ke X, Wang Q, Wang J, Li D, et al. H. pyloriAssociation between infection and colorectal polyps: a Meta-analysis of Observational Studies. Front Med. 2021;8:706036.CrossRef
12.
go back to reference Huang L, Wu L, Qiao Q, Fang L. Correlation between Colon polyps and metabolic syndrome and HP infection status. Gastroenterol Res Pract. 2019;2019:3916154.CrossRefPubMedPubMedCentral Huang L, Wu L, Qiao Q, Fang L. Correlation between Colon polyps and metabolic syndrome and HP infection status. Gastroenterol Res Pract. 2019;2019:3916154.CrossRefPubMedPubMedCentral
13.
go back to reference Murata M, Sugimoto M, Otsuka T, Nishida A, Inatomi O, Bamba S, et al. Successful Helicobacter pylori eradication therapy improves symptoms of chronic constipation. Helicobacter. 2018;23(6):e12543.CrossRefPubMed Murata M, Sugimoto M, Otsuka T, Nishida A, Inatomi O, Bamba S, et al. Successful Helicobacter pylori eradication therapy improves symptoms of chronic constipation. Helicobacter. 2018;23(6):e12543.CrossRefPubMed
14.
go back to reference He X, Wu K, Ogino S, Giovannucci E, Chan A, Song M. Association between Risk factors for Colorectal Cancer and Risk of Serrated polyps and conventional adenomas. Gastroenterology. 2018;155(2):355–73e18.CrossRefPubMed He X, Wu K, Ogino S, Giovannucci E, Chan A, Song M. Association between Risk factors for Colorectal Cancer and Risk of Serrated polyps and conventional adenomas. Gastroenterology. 2018;155(2):355–73e18.CrossRefPubMed
15.
go back to reference Okamoto K, Kitamura S, Kimura T, Nakagawa T, Sogabe M, Miyamoto H, et al. Clinicopathological characteristics of serrated polyps as precursors to colorectal cancer: current status and management. J Gastroenterol Hepatol. 2017;32(2):358–67.CrossRefPubMed Okamoto K, Kitamura S, Kimura T, Nakagawa T, Sogabe M, Miyamoto H, et al. Clinicopathological characteristics of serrated polyps as precursors to colorectal cancer: current status and management. J Gastroenterol Hepatol. 2017;32(2):358–67.CrossRefPubMed
16.
go back to reference Rodrigues-Pinto E, Ferreira-Silva J, Macedo G, Rex D. (Technically) difficult colonoscope insertion - Tips and tricks. Dig endoscopy: official J Japan Gastroenterological Endoscopy Soc. 2019;31(5):583–7.CrossRef Rodrigues-Pinto E, Ferreira-Silva J, Macedo G, Rex D. (Technically) difficult colonoscope insertion - Tips and tricks. Dig endoscopy: official J Japan Gastroenterological Endoscopy Soc. 2019;31(5):583–7.CrossRef
17.
go back to reference Sonnenberg A, Genta R. Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol. 2013;108(2):208–15.CrossRefPubMed Sonnenberg A, Genta R. Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol. 2013;108(2):208–15.CrossRefPubMed
18.
go back to reference Georgopoulos S, Polymeros D, Triantafyllou K, Spiliadi C, Mentis A, Karamanolis D, et al. Hypergastrinemia is associated with increased risk of distal colon adenomas. Digestion. 2006;74(1):42–6.CrossRefPubMed Georgopoulos S, Polymeros D, Triantafyllou K, Spiliadi C, Mentis A, Karamanolis D, et al. Hypergastrinemia is associated with increased risk of distal colon adenomas. Digestion. 2006;74(1):42–6.CrossRefPubMed
19.
go back to reference Watson SA, Smith AM. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis. Cancer Res. 2001;61(2):625–31.PubMed Watson SA, Smith AM. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis. Cancer Res. 2001;61(2):625–31.PubMed
20.
go back to reference Robertson D, Sandler R, Ahnen D, Greenberg E, Mott L, Cole B, et al. Gastrin, Helicobacter pylori, and colorectal adenomas. Clin Gastroenterol hepatology: official Clin Pract J Am Gastroenterological Association. 2009;7(2):163–7.CrossRef Robertson D, Sandler R, Ahnen D, Greenberg E, Mott L, Cole B, et al. Gastrin, Helicobacter pylori, and colorectal adenomas. Clin Gastroenterol hepatology: official Clin Pract J Am Gastroenterological Association. 2009;7(2):163–7.CrossRef
21.
go back to reference Soylu A, Ozkara S, Alis H, Dolay K, Kalayci M, Yasar N, et al. Immunohistochemical testing for Helicobacter Pylori existence in neoplasms of the colon. BMC Gastroenterol. 2008;8:35.CrossRefPubMedPubMedCentral Soylu A, Ozkara S, Alis H, Dolay K, Kalayci M, Yasar N, et al. Immunohistochemical testing for Helicobacter Pylori existence in neoplasms of the colon. BMC Gastroenterol. 2008;8:35.CrossRefPubMedPubMedCentral
22.
go back to reference Shimoda A, Ueda K, Nishiumi S, Murata-Kamiya N, Mukai S, Sawada S, et al. Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA. Sci Rep. 2016;6:18346.CrossRefPubMedPubMedCentral Shimoda A, Ueda K, Nishiumi S, Murata-Kamiya N, Mukai S, Sawada S, et al. Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA. Sci Rep. 2016;6:18346.CrossRefPubMedPubMedCentral
23.
go back to reference Kawahara Y, Kodama M, Mizukami K, Saito T, Hirashita Y, Sonoda A, et al. Endoscopic gastric mucosal atrophy as a predictor of colorectal polyps: a large scale case-control study. J Clin Biochem Nutr. 2019;65(2):153–9.CrossRefPubMedPubMedCentral Kawahara Y, Kodama M, Mizukami K, Saito T, Hirashita Y, Sonoda A, et al. Endoscopic gastric mucosal atrophy as a predictor of colorectal polyps: a large scale case-control study. J Clin Biochem Nutr. 2019;65(2):153–9.CrossRefPubMedPubMedCentral
24.
go back to reference Kumar A, Kim M, Lukin D. Helicobacter pylori is associated with increased risk of serrated colonic polyps: analysis of serrated polyp risk factors. Indian J gastroenterology: official J Indian Soc Gastroenterol. 2018;37(3):235–42.CrossRef Kumar A, Kim M, Lukin D. Helicobacter pylori is associated with increased risk of serrated colonic polyps: analysis of serrated polyp risk factors. Indian J gastroenterology: official J Indian Soc Gastroenterol. 2018;37(3):235–42.CrossRef
25.
go back to reference Garrett W. The gut microbiota and colon cancer. Sci (New York NY). 2019;364(6446):1133–5.CrossRef Garrett W. The gut microbiota and colon cancer. Sci (New York NY). 2019;364(6446):1133–5.CrossRef
26.
go back to reference Chattopadhyay I, Dhar R, Pethusamy K, Seethy A, Srivastava T, Sah R, et al. Exploring the role of gut microbiome in Colon cancer. Appl Biochem Biotechnol. 2021;193(6):1780–99.CrossRefPubMed Chattopadhyay I, Dhar R, Pethusamy K, Seethy A, Srivastava T, Sah R, et al. Exploring the role of gut microbiome in Colon cancer. Appl Biochem Biotechnol. 2021;193(6):1780–99.CrossRefPubMed
27.
go back to reference Wong S, Zhao L, Zhang X, Nakatsu G, Han J, Xu W, et al. Gavage of fecal samples from patients with Colorectal Cancer promotes intestinal carcinogenesis in germ-free and conventional mice. Gastroenterology. 2017;153(6):1621–33e6.CrossRefPubMed Wong S, Zhao L, Zhang X, Nakatsu G, Han J, Xu W, et al. Gavage of fecal samples from patients with Colorectal Cancer promotes intestinal carcinogenesis in germ-free and conventional mice. Gastroenterology. 2017;153(6):1621–33e6.CrossRefPubMed
28.
go back to reference Iino C, Shimoyama T, Chinda D, Arai T, Chiba D, Nakaji S, et al. Helicobacter pyloriInfection of and Atrophic Gastritis Influence in Gut Microbiota in a japanese Population. Front Immunol. 2018;9:712.CrossRefPubMedPubMedCentral Iino C, Shimoyama T, Chinda D, Arai T, Chiba D, Nakaji S, et al. Helicobacter pyloriInfection of and Atrophic Gastritis Influence in Gut Microbiota in a japanese Population. Front Immunol. 2018;9:712.CrossRefPubMedPubMedCentral
29.
go back to reference Vacante M, Ciuni R, Basile F, Biondi A. Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence. Biomedicines. 2020;8(11). Vacante M, Ciuni R, Basile F, Biondi A. Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence. Biomedicines. 2020;8(11).
30.
go back to reference Lee J, Park H, Choi J, Lee J, Koo J, Chung E, et al. Helicobacter pylori infection with atrophic gastritis is an independent risk factor for Advanced Colonic Neoplasm. Gut Liver. 2016;10(6):902–9.CrossRefPubMedPubMedCentral Lee J, Park H, Choi J, Lee J, Koo J, Chung E, et al. Helicobacter pylori infection with atrophic gastritis is an independent risk factor for Advanced Colonic Neoplasm. Gut Liver. 2016;10(6):902–9.CrossRefPubMedPubMedCentral
31.
go back to reference Sonnenberg A, Turner K, Genta R. Associations between gastric histopathology and the occurrence of colonic polyps. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland. 2020;22(7):814–7.CrossRefPubMed Sonnenberg A, Turner K, Genta R. Associations between gastric histopathology and the occurrence of colonic polyps. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland. 2020;22(7):814–7.CrossRefPubMed
32.
go back to reference Kanno T, Matsuki T, Oka M, Utsunomiya H, Inada K, Magari H, et al. Gastric acid reduction leads to an alteration in lower intestinal microflora. Biochem Biophys Res Commun. 2009;381(4):666–70.CrossRefPubMed Kanno T, Matsuki T, Oka M, Utsunomiya H, Inada K, Magari H, et al. Gastric acid reduction leads to an alteration in lower intestinal microflora. Biochem Biophys Res Commun. 2009;381(4):666–70.CrossRefPubMed
33.
go back to reference Inoue I, Kato J, Tamai H, Iguchi M, Maekita T, Yoshimura N, et al. Helicobacter pylori-related chronic gastritis as a risk factor for colonic neoplasms. World J Gastroenterol. 2014;20(6):1485–92.CrossRefPubMedPubMedCentral Inoue I, Kato J, Tamai H, Iguchi M, Maekita T, Yoshimura N, et al. Helicobacter pylori-related chronic gastritis as a risk factor for colonic neoplasms. World J Gastroenterol. 2014;20(6):1485–92.CrossRefPubMedPubMedCentral
Metadata
Title
Atrophic gastritis rather than Helicobacter pylori infection can be an independent risk factor of colorectal polyps: a retrospective study in China
Authors
Zhang Shao-hua
Ren Lin-lin
Su Shen
Tang Yun-he
Tian Zi-bin
Liu Yi
Mao Tao
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02764-w

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.